I have a tremendous interest in exploiting TMS in neuroimaging experiments. In particular, I am interested in pursuing a better understanding of the mechanism by which TMS serves to alter functional networks in patients with major depressive disorder, and the biomarkers that allow some patients to benefit from such treatments while others don’t. This can be explored using multi-modalities including EEG, MEG and fMRI recordings from patients at baseline and after undergoing treatment with TMS. Furthermore, TMS can be utilized in cognitive experiments to manipulate brain function in order to test various hypotheses.